Draw my life: How I almost died from taking birth control

The use of hormonal birth control has magnified over the years due to its increasing popularity and easy access to prescriptions. This video aims to raise awareness about the potential risks
and harmful side effects associated with oral contraceptive pills. Inspired by a true story, this video will promote safety by specifically exploring the relationship between birth control pills and blood clotting, touching upon inherited diseases as well. 
 
This video was made by McMaster Demystifying Medicine students Marija Damjanovska, Sherry
Feldman, Rammiyaa Devan, Raavi Parhar, Veronica Sunbaty.

Copyright McMaster University 2019.

References: 

Bonnar, J. (1987). Coagulation effects of oral contraception. American journal of obstetrics and gynecology, 157(4), 1042-1048.

Griffin, J. H., Evatt, B. R. U. C. E., Zimmerman, T. S., Kleiss, A. J., & Wideman, C. (1981). Deficiency of protein C in congenital thrombotic disease. The Journal of clinical investigation, 68(5), 1370-1373.

Nightingale, A. L., Lawrenson, R. A., Simpson, E. L., Williams, T. J., MacRae, K. D., & Farmer, R. D. T. (2000). The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives. The European Journal of Contraception and Reproductive Health Care, 5(4), 265-274.

O'Brien, S. H. (2014, February). Contraception-related venous thromboembolism in adolescents. In Seminars in thrombosis and hemostasis (Vol. 40, No. 01, pp. 066-071). Thieme Medical Publishers.

Perrier, A., Desmarais, S., Goehring, C., de MOERLOOSE, P. H. I. L. I. P. P. E., Morabia, A., Unger, P. F., ... & Bounameaux, H. (1997). D-dimer testing for suspected pulmonary embolism in outpatients.American journal of respiratory and critical care medicine, 156(2), 492-496.

Protein C deficiency - Genetics Home Reference - NIH. (n.d.). Retrieved November 8, 2019, from https://ghr.nlm.nih.gov/condition/pro...

Rotermann, M., Dunn, S., & Black, A. (2015). Oral contraceptive use among women aged 15 to 49: results from the Canadian Health Measures Survey. Statistics Canada.

Suchon, P., Al Frouh, F., Henneuse, A., Ibrahim, M., Brunet, D., Barthet, M. C., ... & Morange, P. E. (2016). Risk factors for venous thromboembolism in women under combined oral contraceptive. Thrombosis and haemostasis, 115(01), 135-142.

Tait, R. C., Walker, I. D., Reitsma, P. H., Islam, S. I. A. M., McCall, F., Poort, S. R., ... & Bertina, R. M. (1995). Prevalence of protein C deficiency in the healthy population. Thrombosis and haemostasis,
73(01), 087-093.

Vandenbroucke, J. P., Rosing, J., Bloemenkamp, K. W., Middeldorp, S., Helmerhorst, F. M., Bouma, B. N., & Rosendaal, F. R. (2001). Oral contraceptives and the risk of venous thrombosis. New England Journal of Medicine, 344(20), 1527-1535.

Zakharova, M. Y., Meyer, R. M., Brandy, K. R., Datta, Y. H., Joseph, M. S., Schreiner, P. J., ... & Divani, A. A. (2011). Risk factors for heart attack, stroke, and venous thrombosis associated with hormonal contraceptive use. Clinical and applied thrombosis/hemostasis, 17(4), 323-331.